WallStSmart

Core Laboratories NV (CLB)vsNOV Inc. (NOV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NOV Inc. generates 1557% more annual revenue ($8.69B vs $524.73M). CLB leads profitability with a 5.5% profit margin vs 1.1%. NOV appears more attractively valued with a PEG of 1.31. NOV earns a higher WallStSmart Score of 47/100 (D+).

CLB

Hold

47

out of 100

Grade: D+

Growth: 2.7Profit: 5.0Value: 7.3Quality: 8.0
Piotroski: 4/9Altman Z: 2.36

NOV

Hold

47

out of 100

Grade: D+

Growth: 3.3Profit: 4.5Value: 4.3Quality: 6.5
Piotroski: 3/9Altman Z: 1.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLBUndervalued (+65.9%)

Margin of Safety

+65.9%

Fair Value

$55.60

Current Price

$12.93

$42.67 discount

UndervaluedFair: $55.60Overvalued

Intrinsic value data unavailable for NOV.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLB2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.159/10

Conservative balance sheet, low leverage

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

NOV1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Areas to Watch

CLB4 concerns · Avg: 2.8/10
Market CapQuality
$629.68M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Operating MarginProfitability
1.6%3/10

Operating margin of 1.6%

Revenue GrowthGrowth
-1.4%2/10

Revenue declined 1.4%

NOV4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.954/10

Grey zone — moderate risk

Return on EquityProfitability
1.5%3/10

ROE of 1.5% — below average capital efficiency

Profit MarginProfitability
1.1%3/10

1.1% margin — thin

Operating MarginProfitability
2.3%3/10

Operating margin of 2.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : CLB

The strongest argument for CLB centers on Debt/Equity, Price/Book. PEG of 1.44 suggests the stock is reasonably priced for its growth.

Bull Case : NOV

The strongest argument for NOV centers on Price/Book. PEG of 1.31 suggests the stock is reasonably priced for its growth.

Bear Case : CLB

The primary concerns for CLB are Market Cap, Profit Margin, Operating Margin.

Bear Case : NOV

The primary concerns for NOV are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 84.5x leaves little room for execution misses. Thin 1.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

CLB carries more volatility with a beta of 0.99 — expect wider price swings.

CLB is growing revenue faster at -1.4% — sustainability is the question.

CLB generates stronger free cash flow (-926,000), providing more financial flexibility.

Monitor OIL & GAS EQUIPMENT & SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CLB scores higher overall (47/100 vs 47/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Core Laboratories NV

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

Core Laboratories NV (CLB) is a premier provider of specialized reservoir optimization services and products within the oil and gas sector, dedicated to enhancing reservoir characterization and production efficiency. The company employs advanced technologies and proprietary analytics to deliver innovative solutions while maintaining a strong commitment to sustainability. With a robust global footprint, Core Labs is strategically positioned to capitalize on new growth opportunities and adeptly address the evolving challenges in the dynamic energy landscape.

Visit Website →

NOV Inc.

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

NOV Inc. is an American multinational corporation based in Houston, Texas. It is a leading worldwide provider of equipment and components used in oil and gas drilling and production operations, oilfield services, and supply chain integration services to the upstream oil and gas industry.

Visit Website →

Want to dig deeper into these stocks?